Finance

Lists
GETI-B:STO
Getinge publ AB
253,20 SEK
+1,44%
(+3,60) 1D
9 հոկ, 17:29:44 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for GETI-B...
Open
249,60 SEK
High
255,90 SEK
Low
249,30 SEK
Mkt. cap
64,35 մլրդ
Avg. vol.
594,80 հզր
Volume
527,55 հզր
Dividend
1,88%
Quarterly dividend
1,19 SEK
Ex-dividend date
22 ապր, 2026 թ.
P/E ratio
25,79
52-wk high
255,90 SEK
52-wk low
175,90 SEK
EPS
9,82 SEK
Shares outstanding
254,15 մլն
No. of employees
12 հզր
Open
249,60 SEK
High
255,90 SEK
Low
249,30 SEK
Mkt. cap
64,35 մլրդ
Avg. vol.
594,80 հզր
Volume
527,55 հզր
Dividend
1,88%
Quarterly dividend
1,19 SEK
Ex-dividend date
22 ապր, 2026 թ.
P/E ratio
25,79
52-wk high
255,90 SEK
52-wk low
175,90 SEK
EPS
9,82 SEK
Shares outstanding
254,15 մլն
No. of employees
12 հզր
News stories
From web sources and news partners
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB
CEOMattias Perjos
Employees11,8 հզր
Founded1904
Headquarters-
Sector-
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
8,23 մլրդ
10,19 մլրդ
7,44 մլրդ
8,38 մլրդ
Cost of goods sold
4,41 մլրդ
5,38 մլրդ
3,84 մլրդ
3,96 մլրդ
Cost of revenue
4,41 մլրդ
5,38 մլրդ
3,84 մլրդ
3,96 մլրդ
Research and development expenses
307,00 մլն
484,00 մլն
328,00 մլն
358,00 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,51 մլրդ
2,76 մլրդ
2,55 մլրդ
2,71 մլրդ
Operating expense
2,83 մլրդ
3,10 մլրդ
2,87 մլրդ
3,06 մլրդ
Total operating expenses
7,24 մլրդ
8,49 մլրդ
6,70 մլրդ
7,03 մլրդ
Operating income
985,00 մլն
1,70 մլրդ
738,00 մլն
1,35 մլրդ
Other non operating income
2,00 մլն
-105,00 մլն
-1,00 մլն
-
EBT including unusual items
790,00 մլն
1,21 մլրդ
572,00 մլն
1,15 մլրդ
EBT excluding unusual items
824,00 մլն
1,26 մլրդ
602,00 մլն
1,22 մլրդ
Income tax expense
214,00 մլն
338,00 մլն
170,00 մլն
312,00 մլն
Effective tax rate
27,09%
28,03%
29,72%
27,11%
Other operating expenses
17,00 մլն
-136,00 մլն
-12,00 մլն
-
Net income
566,00 մլն
868,00 մլն
401,00 մլն
841,00 մլն
Net profit margin
6,88%
8,52%
5,39%
10,03%
Earnings per share
2,42
4,45
1,80
3,59
Interest and investment income
-
73,00 մլն
-
-
Interest expense
-163,00 մլն
-103,00 մլն
-135,00 մլն
-133,00 մլն
Net interest expenses
-163,00 մլն
-30,00 մլն
-135,00 մլն
-133,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,27 մլրդ
1,97 մլրդ
1,01 մլրդ
1,63 մլրդ
Gain or loss from assets sale
-
40,00 մլն
-
-
AI content may include mistakes. Learn more
Google Apps